We focus on bringing advanced protein-based technologies for everything from antigen-driven immune responses to production and characterization of high quality antibodies for disease treatment. This includes high-throughput recombinant expression and purification of soluble and membrane proteins, biophysical characterization, binding and functional validation, and developability analysis. We also perform protein engineering to optimize sequences and to unlock advanced therapeutic formats from bispecifics to CAR-T cell therapies.